Outset Medical Soars 32.6% on Bullish Outlook

Outset Medical's stock surged 32.6% in pre-market trading on April 11, 2025, marking a significant rise that has caught the attention of investors and analysts alike.

Outset Medical recently released its Q4 2024 earnings report on February 19, 2025, which showed an EPS of -$6.90, falling short of the consensus estimate of -$6.30 by $0.60. This earnings miss could have contributed to the recent volatility in the stock price.

The company has a consensus price target of $35.00, suggesting a potential upside of 269.20%. This optimistic outlook, despite the recent earnings miss, indicates that analysts remain bullish on the company's long-term prospects.

Given the current short-term trend, the stock is expected to rise 340.98% during the next 3 months, with a 90% probability of holding a price between $14.17 and higher. This forecast reflects the market's confidence in the company's future performance.